Statins lower LDL primarily through which mechanism?

Prepare for the Mehlman Cardiology Exam. Engage with interactive quizzes, flashcards, and detailed explanations for each cardiology topic. Ace your exam with our comprehensive study tools!

Multiple Choice

Statins lower LDL primarily through which mechanism?

Explanation:
Statins lower LDL primarily by inhibiting the enzyme HMG-CoA reductase in the liver. This competitive, reversible inhibition reduces hepatic cholesterol synthesis, which lowers intracellular cholesterol. In response, hepatocytes upregulate LDL receptors, increasing clearance of LDL cholesterol from the blood and thus lowering LDL-C. This mechanism is distinct from agents that block intestinal cholesterol absorption (ezetimibe) or activate PPAR-alpha (fibrates). While statins can modestly increase PCSK9 levels, that is not the main way they reduce LDL; the key effect is HMG-CoA reductase inhibition leading to more LDL receptor–mediated clearance.

Statins lower LDL primarily by inhibiting the enzyme HMG-CoA reductase in the liver. This competitive, reversible inhibition reduces hepatic cholesterol synthesis, which lowers intracellular cholesterol. In response, hepatocytes upregulate LDL receptors, increasing clearance of LDL cholesterol from the blood and thus lowering LDL-C. This mechanism is distinct from agents that block intestinal cholesterol absorption (ezetimibe) or activate PPAR-alpha (fibrates). While statins can modestly increase PCSK9 levels, that is not the main way they reduce LDL; the key effect is HMG-CoA reductase inhibition leading to more LDL receptor–mediated clearance.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy